228 related articles for article (PubMed ID: 26799259)
41. Surgical Treatment of Medullary Thyroid Cancer.
Machens A; Dralle H
Recent Results Cancer Res; 2015; 204():187-205. PubMed ID: 26494390
[TBL] [Abstract][Full Text] [Related]
42. Skip metastases in thyroid cancer leaping the central lymph node compartment.
Machens A; Holzhausen HJ; Dralle H
Arch Surg; 2004 Jan; 139(1):43-5. PubMed ID: 14718274
[TBL] [Abstract][Full Text] [Related]
43. RET gene mutation analysis and long-term clinical outcomes of medullary thyroid cancer patients.
Prabhu M; Shakya S; Ballal S; Ahmed Shamim S; Bal C
Nucl Med Commun; 2020 Nov; 41(11):1136-1142. PubMed ID: 32796450
[TBL] [Abstract][Full Text] [Related]
44. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
45. Nodal metastasis microRNA expression correlates with the primary tumour in MTC.
Gundara JS; Zhao JT; Gill AJ; Clifton-Bligh R; Robinson BG; Delbridge L; Sidhu SB
ANZ J Surg; 2014 Apr; 84(4):235-9. PubMed ID: 23072640
[TBL] [Abstract][Full Text] [Related]
46. Current management of medullary thyroid cancer.
Sippel RS; Kunnimalaiyaan M; Chen H
Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
[TBL] [Abstract][Full Text] [Related]
47. [Medullary thyroid carcinoma--current surgical aspects. Overview and retrospective analysis of 22 cases].
Todorov G; Petkov R; Lukanova Ts; Koĭchev A; Mladenovski V; Kŭtev N; Iarŭmov N
Khirurgiia (Sofiia); 2006; (4-5):5-8. PubMed ID: 18846693
[TBL] [Abstract][Full Text] [Related]
48. [Prognostic value of clinical, histopathological and immunohistochemical features in medullary thyroid cancer].
Ríos A; Rodríguez JM; Febrero B; Acosta JM; Torregrosa N; Parrilla P
Med Clin (Barc); 2012 Sep; 139(7):277-83. PubMed ID: 22032817
[TBL] [Abstract][Full Text] [Related]
49. [Lymph node involvement and prognosis in medullary cancers of the thyroid gland].
Mathonnet M; Cubertafond P; Teissier MP; Boutros-Toni F; Gainant A
Chirurgie; 1994-1995; 120(12):117-22. PubMed ID: 8746014
[TBL] [Abstract][Full Text] [Related]
50. Initial lymph node dissection increases cure rates in patients with medullary thyroid cancer.
Greenblatt DY; Elson D; Mack E; Chen H
Asian J Surg; 2007 Apr; 30(2):108-12. PubMed ID: 17475579
[TBL] [Abstract][Full Text] [Related]
51. Clinicopathological and prognostic analysis of follicular thyroid carcinoma in a single institute over a 15-year period.
Yu XF; Wang WB; Teng XD; Wang HY; Chen X; Wang HH; Ma ZM; Fahey TJ; Teng LS
Eur J Surg Oncol; 2014 Jul; 40(7):869-74. PubMed ID: 24613740
[TBL] [Abstract][Full Text] [Related]
52. Simultaneous medullary and papillary thyroid cancer: a novel entity?
Machens A; Dralle H
Ann Surg Oncol; 2012 Jan; 19(1):37-44. PubMed ID: 21626080
[TBL] [Abstract][Full Text] [Related]
53. Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: Different biology.
Machens A; Dralle H
Eur J Surg Oncol; 2015 Jun; 41(6):766-72. PubMed ID: 25468749
[TBL] [Abstract][Full Text] [Related]
54. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
[TBL] [Abstract][Full Text] [Related]
55. Correlation of minimal extrathyroidal extension with pathologic features of lymph node metastasis in patients with papillary thyroid carcinoma.
Lee HS; Park C; Kim SW; Park T; Chun BK; Hong JC; Lee KD
J Surg Oncol; 2015 Nov; 112(6):592-6. PubMed ID: 26421594
[TBL] [Abstract][Full Text] [Related]
56. Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience.
Torresan F; Cavedon E; Mian C; Iacobone M
World J Surg; 2018 Feb; 42(2):367-375. PubMed ID: 29134313
[TBL] [Abstract][Full Text] [Related]
57. Disparities between male and female patients with thyroid cancers: sex difference or gender divide?
Machens A; Hauptmann S; Dralle H
Clin Endocrinol (Oxf); 2006 Oct; 65(4):500-5. PubMed ID: 16984243
[TBL] [Abstract][Full Text] [Related]
58. Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years.
Randle RW; Balentine CJ; Leverson GE; Havlena JA; Sippel RS; Schneider DF; Pitt SC
Surgery; 2017 Jan; 161(1):137-146. PubMed ID: 27842913
[TBL] [Abstract][Full Text] [Related]
59. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
60. Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis.
Qu N; Shi RL; Lu ZW; Liao T; Wen D; Sun GH; Li DS; Ji QH
Oncotarget; 2016 Oct; 7(40):65937-65945. PubMed ID: 27588396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]